





<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  


<head>
      <script type="text/javascript">
    var otsuka_dl = { 
    "page": {
        "business_function": "commercial", 
        "therapeutic_area": "nephrology", 
        "business_affiliate": "oapi", 
        "site_language": "english", 
        "brand_name": "jynarque", 
        "side_of_brand": "hcp", 
        "indication": "autosomal dominant polycystic kidney disease (adpkd)", 
        "root_domain": "jynarquehcp.com"
    } 
};
  </script>

        <title>Identify ADPKD Patients | HCP JYNARQUE® (tolvaptan) tablets</title>
    <meta charset="utf-8" />
<meta name="description" content="Review a holistic assessment for identifying appropriate patients for JYNARQUE® (tolvaptan). See FULL PRESCRIBING INFORMATION, including BOXED WARNING." />
<meta name="keywords" content="ADPKD, autosomal dominant polycystic kidney disease, tolvaptan, JYNARQUE" />
<link rel="canonical" href="identify-patients.html" />
<meta name="google-site-verification" content="S979W9LEDXsQQvi7sUkEAwBRLEs0M_9EhYns57YIycs" />
<meta name="Generator" content="Drupal 10 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0190fcfe-c0de-7b85-b039-75fd69273f8a" defer="defer"></script>
<script type="text/javascript" defer="defer">
  function waitForElm(selector) {
    return new Promise(function (resolve) {
      if (document.querySelector(selector)) {
        return resolve(document.querySelector(selector));
      }
      const observer = new MutationObserver(function (mutations) {
        if (document.querySelector(selector)) {
          observer.disconnect();
          resolve(document.querySelector(selector));
        }
      });
      observer.observe(document.body, {
        childList: true,
        subtree: true
      });
    });
  }
  function oneTrustAddFont() {
    const link = document.createElement('link');
    link.rel = 'stylesheet';
    link.type = 'text/css';
    link.href = 'https://fonts.googleapis.com/css?family=Montserrat';
    document.getElementsByTagName('HEAD')[0].appendChild(link);
  }
  function addMeta() {
    const meta = document.createElement('meta');
    meta.name = 'viewport';
    meta.content = 'width=device-width, initial-scale=1.0';
    document.getElementsByTagName('head')[0].appendChild(meta);
  }
  function oneTrustBannerFooterFix() {
    const divSelector = document.querySelector('#onetrust-button-group-parent');
    const elementDiv = document.createElement('div');
    elementDiv.className = 'ontrust_logo';
    elementDiv.innerHTML = "<div class='green-logo'> onetrust</div><div class='text-logo'>Powered by</div>";
    divSelector.parentNode.insertBefore(elementDiv, divSelector.nextSibling);
    document.getElementsByClassName('ot-pc-footer-logo')[0].children[0].removeAttribute('href');
  }
  function oneTrustBannerOtherFix() {
    var p = document.querySelectorAll('.ot-accordion-layout p');
    Array.prototype.forEach.call(p, function(el) {
      el.innerHTML = el.innerHTML.replace(/&nbsp;/gi, '');
    });
    let tabindex = 2;
    document.querySelectorAll('#onetrust-button-group button, #onetrust-button-group input').forEach(function (element) {
      element.setAttribute('tabindex', String(tabindex));
      if (tabindex === 2) {
        tabindex = 1;
      } else if (tabindex === 1) {
        tabindex = 3;
      } else {
        tabindex++;
      }
    });
    document.querySelector('#onetrust-policy-text a').setAttribute('tabindex', 1);
  }
  function oneTrustSettingsButtonFix() {
    const acceptBtn = document.getElementById('accept-recommended-btn-handler');
    const rejectBtn = document.getElementsByClassName('ot-pc-refuse-all-handler')[0];
    const container = document.getElementsByClassName('ot-btn-container')[0];
    container.prepend(acceptBtn, rejectBtn);
  }
  function oneTrustSettingsOtherFix() {
    const modelElement = document.getElementById('onetrust-pc-sdk');
    document.addEventListener('focus', function (e) {
      const focusableElements = modelElement.querySelectorAll('a[href], area[href], input:not([disabled]), select:not([disabled]), textarea:not([disabled]), button:not([disabled]), iframe, object, embed, *[tabindex], *[contenteditable]');
      if (!Array.from(focusableElements).includes(e.target)) {
        Array.from(focusableElements)[0].focus();
      }
    }, true);
  }
  oneTrustAddFont();
  addMeta();
  document.addEventListener('DOMContentLoaded', function () {
    waitForElm('#onetrust-banner-sdk').then(function () {
      oneTrustBannerFooterFix();
      oneTrustBannerOtherFix();
    });
    waitForElm('#onetrust-pc-sdk').then(function () {
      oneTrustSettingsButtonFix();
      oneTrustSettingsOtherFix();
    });
  });
</script>
<script></script>
<link rel="preconnect" href="https://fonts.googleapis.com/" />
<link rel="preconnect" href="https://fonts.gstatic.com/" crossorigin="anonymous" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Source+Sans+Pro:ital,wght@0,300;0,400;0,600;0,700;0,900;1,300;1,400;1,700&amp;display=swap" type="text/css" />
<script src="https://assets.adobedtm.com/3f0d2e2dbd42/313fd7baa8af/launch-bacdce8b01b7.min.js" type="text/javascript" async></script>
<meta name="format-detection" content="telephone=no" />
<link rel="icon" href="sites/g/files/qhldwo11641/files/favicon.ico" type="image/vnd.microsoft.icon" />
<script type="application/ld+json">{
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "audience": "Clinician",
    "specialty": "Renal",
    "url": "https://www.jynarquehcp.com/identify-patients",
    "headline": [
        "With ADPKD, there is a lot to consider",
        "Patients with stable eGFR could be at risk of rapid progression1,2",
        "Kidney growth and damage often occur before kidney function declines1,3,5",
        "2-step risk identification can help determine if JYNARQUE is appropriate for your patients whose eGFR appears stable",
        "Even when eGFR appears normal, irreversible kidney damage may still be occurring1,2",
        "If at least ONE risk factor is identified, a kidney measurement should be ordered",
        "Rapidly declining eGFR means the risk of ADPKD progression is fully realized3,4"
    ],
    "abstract": "Measuring eGFR alone doesn't always reveal how ADPKD is progressing1",
    "description": [
        "Patients presenting with any of these independently validated risk factors could be experiencing rapid ADPKD progression6",
        "Kidney size is a strong predictor of ADPKD progression before eGFR begins to decline9",
        "A CRISP cohort analysis, published in Kidney International, showed that a one-time TKV measurement can help assess the rate of future kidney function decline10",
        "When requesting kidney measurements, ask the radiologist for: Maximal bilateral kidney dimensions (L x W x D) and/or A calculated TKV",
        "When you receive measurements: Plot TKV on the Mayo Imaging Classification tool to determine the risk of progression and appropriateness for treatment11",
        "Rapid disease progression is defined as reliable eGFR decline ≥3.0 mL/min/1.73 m2 per year over a period of ≥4 years with no other confounding cause than ADPKD and indexed for age: 18-39 years: any eGFR; 40-44 years: eGFR &lt;90 mL/min/1.73 m2; 45-49 years: eGFR &lt;75 mL/min/1.73 m2; 50-55 years: eGFR &lt;60 mL/min/1.73 m2.4",
        "If your patients are showing evidence of rapidly progressing ADPKD, consider whether JYNARQUE may be an appropriate treatment choice."
    ],
    "name": "Patient Identification",
    "breadcrumb": {
        "@type": "BreadcrumbList",
        "itemListElement": [
            {
                "@type": "ListItem",
                "position": 1,
                "item": {
                    "@id": "https://www.jynarquehcp.com/",
                    "name": "Homepage"
                }
            },
            {
                "@type": "ListItem",
                "position": 2,
                "item": {
                    "@id": "https://www.jynarquehcp.com/identify-patients",
                    "name": "Patient Identification"
                }
            }
        ]
    },
    "mainContentOfPage": {
        "@type": "WebPageElement",
        "potentialAction": [
            {
                "@type": "Action",
                "name": "Pivotal Trial Data",
                "description": "Supporting Information",
                "url": "https://jynarquehcp.com/pivotal-trial-data"
            },
            {
                "@type": "Action",
                "name": "Full Safety Data",
                "description": "Supporting Information",
                "url": "https://jynarquehcp.com/clinical-information/safety-profile"
            },
            {
                "@type": "Action",
                "name": "Patient Profiles",
                "description": "Supporting Information",
                "url": "https://jynarquehcp.com/patient-profiles"
            },
            {
                "@type": "Action",
                "name": "Patient Counseling Tips",
                "description": "Supporting Information",
                "url": "https://jynarquehcp.com/patient-counseling"
            }
        ]
    },
    "video": [
        {
            "@type": "VideoObject",
            "name": "HEAR ABOUT IDENTIFYING APPROPRIATE PATIENTS FOR JYNARQUE",
            "description": "Hear about identifying appropriate patients for JYNARQUE",
            "thumbnailUrl": [
                "https://i.vimeocdn.com/video/1856653394-298a75469cb15aec74ded6a23cf70ed34d27a32e767900b4a435b94dc7bd5b4b-d_640?f=webp"
            ],
            "uploadDate": "2024-05-22T03:23:46-04:00",
            "duration": "PT226S",
            "contentUrl": "https://www.jynarquehcp.com/identify-patients",
            "embedUrl": "https://player.vimeo.com/video/949037192"
        },
        {
            "@type": "VideoObject",
            "name": "Treating patients with ADPKD when kidney function appears stable",
            "description": "",
            "thumbnailUrl": [
                "https://i.vimeocdn.com/video/1856653394-298a75469cb15aec74ded6a23cf70ed34d27a32e767900b4a435b94dc7bd5b4b-d_640?f=webp"
            ],
            "uploadDate": "2024-05-22T03:23:46-04:00",
            "duration": "PT226S",
            "contentUrl": "https://www.jynarquehcp.com/identify-patients",
            "embedUrl": "https://player.vimeo.com/video/949037192"
        },
        {
            "@type": "VideoObject",
            "name": "Treating patients with rapidly declining eGFR",
            "description": "",
            "thumbnailUrl": [
                "https://i.vimeocdn.com/video/1856653394-298a75469cb15aec74ded6a23cf70ed34d27a32e767900b4a435b94dc7bd5b4b-d_640?f=webp"
            ],
            "uploadDate": "2024-05-22T03:23:46-04:00",
            "duration": "PT226S",
            "contentUrl": "https://www.jynarquehcp.com/identify-patients",
            "embedUrl": "https://player.vimeo.com/video/949037192"
        }
    ],
    "about": [
        {
            "@type": "MedicalCondition",
            "name": "Autosomal Dominant Polycystic Kidney Disease",
            "alternateName": [
                "ADPKD",
                "Autosomal Dominant Polycystic Kidney Disease (ADPKD)"
            ],
            "riskFactor": [
                "Truncating PDK1 mutation7",
                "Overweight and obesity (BMI ≥25 kg/m2)8",
                "Hypertension before age 35",
                "Urologic events before age 35 (gross hematuria, cyst infection, or flank pain related to cysts)",
                "Proteinuria and microalbuminuria",
                "Family history of ESKD at or before age 58"
            ]
        },
        {
            "@type": "MedicalTherapy",
            "guideline": [
                "Strong CYP3A Inducers: Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers",
                "V2-Receptor Agonist: Tolvaptan interferes with the V2-agonist activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a V2-agonist"
            ],
            "adverseOutcome": [
                "Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia."
            ],
            "seriousAdverseOutcome": [
                "Serious Liver Injury: JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.",
                "Hypernatremia, Dehydration and Hypovolemia: JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.",
                "Inhibitors of CYP3A: Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE."
            ],
            "contraindication": [
                "History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease",
                "Taking strong CYP3A inhibitors",
                "With uncorrected abnormal blood sodium concentrations",
                "Unable to sense or respond to thirst",
                "Hypovolemia",
                "Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product",
                "Uncorrected urinary outflow obstruction",
                "Anuria"
            ],
            "recognizingAuthority": {
                "@type": "Organization",
                "name": "U.S. Food and Drug Administration",
                "alternateName": "FDA",
                "url": "https://www.fda.gov/"
            }
        },
        {
            "@type": "Drug",
            "Name": "JYNARQUE®",
            "nonProprietaryName": "tolvaptan",
            "activeIngredient": "tolvaptan",
            "alternateName": "JYNARQUE (tolvaptan)",
            "dosageForm": "tablets",
            "administrationRoute": "oral",
            "doseSchedule": [
                {
                    "@type": "DoseSchedule",
                    "frequency": "Daily",
                    "doseUnit": "mg",
                    "doseValue": [
                        "60",
                        "90",
                        "120"
                    ],
                    "targetPopulation": "adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD)."
                }
            ],
            "offers": {
                "@type": "Offer",
                "description": "Eligible patients pay as little as $10 per month for JYNARQUE*",
                "price": "10",
                "priceCurrency": "USD",
                "url": "https://www.jynarquerems.com/"
            },
            "pregnancyWarning": "Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy.",
            "breastfeedingWarning": "Advise women not to breastfeed during treatment with JYNARQUE.",
            "warning": [
                "JYNARQUE® (tolvaptan) can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported",
                "Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3 months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of hepatic injury can mitigate, but not eliminate, the risk of serious hepatotoxicity",
                "Because of the risks of serious liver injury, JYNARQUE is available only through a Risk Evaluation and Mitigation Strategy program called the JYNARQUE REMS Program"
            ],
            "image": "https://www.jynarquehcp.com/sites/g/files/qhldwo8636/themes/site/themes/custom/jynarque_hcp/assets/build/img/jynarque-logo.png",
            "manufacturer": {
                "@type": "Organization",
                "name": "Otsuka America Pharmaceutical, Inc.",
                "logo": "https://www.jynarquehcp.com/sites/g/files/qhldwo8636/files/inline-images/otsuka_logo2.png"
            }
        }
    ]
}</script>

        <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_97htjIvQ15V1EfeTASftshiMIzLS36LIXVDogWwnlWQ.IJ5KA0xBsRRaiRPaWB6Sh9PN3WKo_EsNIYaw8SqYqYc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Zru9LBZ0sAXcjonUFHSutTAZkU-sNKpHr1JGBQ4FyU0.bkPvoFYCA2Lixa4KISvTdT3EKjCHiKrtKcE261byVx01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_kzULKG5pzGyNLykluQb5oDJTQPcLlJKzZ5imyM6J1h8.b9DwpaiAlb0lsM657D5Lniy-cPNAkk4Cxr45yy473q41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_uI2FntcPi0s7LE7aVRLFPdaOjEJ2AvgJxZxn7U_KEpU.uS1FFwOJYeXSeF3bIVSvkMkrHh5opqqW_F79rAx63B01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_LyrrR6JZO8eTCViUPzg899V1r3IBqMYsy9zQoA-d_xo.Awf46AhlxtFml2KQ8H4-E0dZzxzlJb1Ua0P5_ptOC4k1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_YuXFCqJ6Mh9c2Lz522vxxQKwCuYdi4B4eglcgrxGnjc.xk_yrolxl9EFVCS6-YD3__eEEiB4lkwtBVMLZeTfMbA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Awu9YtmWu_taaaaJKswYqKQEUWlATiU0b-9Ka6etFfU.pYA92qiAPS662AtCQt6lMeZYgkI683UmfkdP-4BIymA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_yIJuzHvo1e460jlmqttlj52OMZk0ZV7QmKCy-1vP5ZI.qAT_vNKdppWlPfwRvdNPIJfErkIfxMw2j_eesucANOI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_xnDYBl4OD9snX7Sf9EyJ9VkzRg71lff1OegyGLU8z1w.l_5ZkiCBh5EcPa_3_oVW7iVMoKNAq5rw47oEzn5A4uM1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_gfUtLDXi72df47AexuJ-vm_wJb2QkME0vEvBnJxO6dA.x5nsh_uKblK9k6iDq9xx7vDex30jZc5ML0YXij4JCf01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_CYXnyo1qFoxHAoBBNsSqN8PVNbP8sxeQ_LtauZ50Wgs.g1uXGwNn2HpE6NbJGbnMjYWIh7kyfoVz_UhSlBh2o3s1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_QF7anExUIQ9m7lRlQYpqk7QebuejK_k7Tyzw3UgZ-hg.PZJw_IXbQZH7i6WEC-FHNDBoI3_PTyzLEmC7wWy4oTU1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_7QllbjqoprdCwoIdo3V7DWqJKkTBOzMJn-xZmsutiww.8xdGy7dXc6zJNYRxgF4k0vgBhKloby5N-_V1MMOlg8A1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_hnJTGN1fzih_ZZssV428NML2NhpFxXlJrqaLNgE8CHo.F9pmb7LygmrpoeT1fXJA7PaAVf2oWybBXF5F5Eihki41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css__13fw7LchbE-h7zw4b3GPIwiFWcaKaefv7L39uOe9so.KNMtBlCBCom77JyoWGB48Q3ueDS7rzZa_7XYX8jrDaA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_0jPT-BWLonFoD1a1XPcxcniBn9WgukRnniaE-xYrMIs.eYuzxX6GcmG8wPZRhL7aCvvGdgilCJbuAMMEoRSvz4o1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_wcTRp4Ty5SGu4F6Mj_Src4xCVH1pAn1ZKdFhbgibbUI.Sk-ip5PYfIjxUJ83DbxAtt7sIYi2qRj5I2X4c7e8Vm01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_XYJeCymlgeYq2fA8gUC7CjnYFGGkur-vgRftab7u22k.kpMc62oK0cmz6PxvM1ud_W8MfI7jbwibsQJBwUKnj6o1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_GbvmbJJu3etNuvRxzgpArn9FbrGIPob5sKfVZm03KVw.b0Zuw7zuYwqRxAI1V79cTc_023d639V2bQ6KyuEtbY01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Q6hS9heFRWwmGWvo9WsD_D6nDHdUaUnYt6sC6_oX9L8.KZBkzzAnxe-rSrbfNF3hMC36Vi24PspRllNxk4SA9Ww1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_41w6dBZ448pJSogyLgoToui9MDm8KnZHhhxIUFUonds.PQ-2T_xzJKQYbbkpGgIM9A4s115DO680EaZM47Z16XI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_JCU_zSqQm3rvBIXWevl-Uch6AS6Fms27h_AxAbdSM2A.2mNgp1qsab5wdrSlpKLQv707xKZ0u6LnqctpgDVxkVk1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css__7a65Qsn2GbI6R4HiSGaSbf2n93vUm8S71hKr7aus8Y.0Qb5zpcCHmzpoF5ZOnDsfklWZn6rg3JsnrG0c7cJ-441cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_PRpLCpZQr4zTfafBQvuU6Ai1fdWr3UHToA3uiawHjkM.fLPfLB0XwmNrMgpuaRfK4T-BBNy7nDIXycFgFzdHoEQ1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_V6iQIpf-C83NZsc_ZHJJ4Q0jrm5R5y5vFIFdUqU6rYw.jljVGWN9UpDBDhlOvibVHSAxjCOZonuvT1tJeWFbkHY1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_JRwBrgzEYGlwc4MToPRbyCOWROVGfhGwZYPeahCS1FQ.x2RHeJP2jfGtOEoBsLLkQsDsiShlMAaWwniIPW_QOWc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Z-5TKx9kThxW5rYM3vQRCBc8GEdIN_NvKS9iqhDQafw.RyxC-gT9frmBMijOhY3C3K32AabFm7-q9HkDsnP6XHU1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_2fOIiKYvhnv1KtlkfBN2k0dROF50_VqtX1AygAXbRUU.a_ZLSp52H6ZconNljM9h1TZl4ovw7N0npH7nKInNWJg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_3QmaP_LDiu3S36EyZEj2za-TqA2bSQCm2AHv-UHH8Yg.hH7cKuhw_G4BiDRPMc9OMcTfof_jG8GOcBK-W90DfUk1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Q7zLgQvyD3dkOHXnT2wFwjtThfQupYWs-a29sqLPi4I.NBaa9xsCtF_rCNvid3JjjAs77Sb-JtnwFbAZvmTkOJs1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_B_2jVuT6jLLyb7aSeSEqk36PnVz0mEI5zK7uqVBaJLw.smsRBGGy-MttVliRuPwj_TEI4mBHLeiSE32C0BkTq6M1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_kJqax_RkZBAk2I3Nq_rTD9LHc0oMwWKlanYK42ORIfM.zTSiciBJCN04ULznc2T1MWG59Py-6ONyTHVVm-YCHX41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_ZLK1vZUalJobqPbcQRSdgxc62n2uq_Ot1d3F3_Ed-GY.jrZk7eEvmjTBJ8HY9yYe_lwEgrl7z1ag2H5wkLbKVgw1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_vOD9-5JiqhFy7oiIOzO00o2XLgmR6XH8SUL8LL585Vc.8e6pTB1_nGdHUV4devYGGEmOgZeQXykLw4UdpB-9VYg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_syNh2ZBM2xlmOdBPf0FR8w7O-hHQEBa956Kp_ldOSBg.xkGZo2gAdcfeCasz9E7IXM7UlmN8zg2sNe-DUmghXI01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_q2E2y5MBPRf422vpPN0DME5tgpDakJKU8shGsBJGndg.qvqk-z17E7JlX9pYx8b0C1UIaYryHrpXqqt4Sdflos01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_kPUtqisf0lrHdJsPV-HJ8wEHOFRbSDxP-pzEt2drCg8.j317pwJpjGUayMMKAkpZNtp2AGp5H841Sotc8GzQsmA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_PqtibPjnERMA4Ua_MJbRjVxbuLrXmo6e3Tu32cUIGlg.0qQgLQQakyHzIK8KF-SO-BSrK2TX62CBX9T8znShQQo1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_HM6QcBbb-L4Y8uofM5-Ls5Jjh9nBZt0_GFIXVcDc2FE.tG7aiOIjno2MCVVs2teyLVCjIbVskLckQTF5jrrTB1g1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_3-74lGc_qnWeX8UeqKX-LZDQJky2QvbaHFfo4iNTZ6k.POmC--YL2K5Oj8dGp36jOmTLjLa3WnQ1Klk-RmN5cKg1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_C5xtDM7MBo92l2HuaBElAFgXGEMnxlbXzAkWYNubwRc.IqgtGKwOBpiL-dymUeH-GFwnVeGT0DnrLjtTJUqL2_41cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_MOe9qRt3CkMNxgnpfPV9Az8ZqOVb46vYdQAgr0avYUU.3MgLUMVsRw5IKzlLPIy_emMSmopYmXsSRQveLYWhSss1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_GuCghzoXuBpA5xW0-r2xpFwn8cmAexGAo2_TqImiAU8.A1Y8b6D3vVIsSyfQqc6LgQ3rxh5EtpBc6eZRBiRA_ig1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_ZlQtfF6UArMuNh04_ViDd_zWzsFVmMhD4gJvAPc37vc.D_G-8MmJ5xcQ2kmeERq3W3mrmsvQku3QFH55n61GsGI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_d3dFkb3e4spT0u0ANbfWFT0aOMfCLEkPbRdscdaUfsU.ySpc8FExUPNbp1UFmrFdfA16Sn6is3GWGXp42BKhrk01cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_ArhVcjF42RZthmSJKRPm09aS8d3gp7Z8I4oGmru4CbI.qYT9Td99YznCgmm79fS72wleHi-1n2IZN6AidXHo08E1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Rz4CyfU-tt37njBy44WX-XrS4zxnMhF_6Go4o7UwLGI.79bAlAvX0LU9yDuY5LxmPLL7t8w3aVVw1vo8avMA8kA1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_2q3_cDI6RdqHnRwH_XgoPOAwo9FXO-tcqG_yT6CPe9s.l458SJWUrwPoMnJnZ_5qDN0jqPz6K5dCJoQ9UXnA_DI1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_0HuNciDfYnF1bgCrWDJ7vWP6DBbES-2NaoX7LS-7J7w.sGFI40X4eJmPcLu8FKNKbJRZE9vl-RCYCItbleoETAc1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_Lln5SjQMuv2n0S-BExbI8cautmTrPcQVykeaA52uFro.s9dBNdMMOtzUsW-YvDIx7BASbgV1sw0AIYdtS9bmP9k1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_B8nrc5EOw0NMSk2BRRcQC0R6-mW2Mi_vNRkAPJvIjZg.vnvsiazk6PwL-f1a7h6bXZCdbHloDT6BoIzwjA2I8So1cee.css?t5xpr9" />
<link rel="stylesheet" media="all" href="sites/g/files/qhldwo11641/files/css/optimized/css_GmyqFQFQe25qXoOyEGVD699zKQpLw_GqHA7ZPIgbbw4.7ZO1nmmOSbqX0BcPwxfG0l3f23_Kbss-E02-PzWTtN41cee.css?t5xpr9" />

    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/38836","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/qhldwo11641\/themes\/site\/themes\/custom\/jynarque_hcp"},"pluralDelimiter":"\u0003","gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJyFkGFyhCAMhS-06pEyAVJkNxIKYV1vX7p1Rm11-oeQ5JvHe6ATQ8BYox0H3DU3L-KZQNEPvh2_-x7v-DoOp9t9iZg_K8Fo0-BZDHJXdOEQ_XEXxVFvkRlUAK0GiSdAiEo5IkNCT8d9wow-Yxp7tFay-yOwARazg_FqG6amDUovBcNiH1fcMzgSKC0JX1kpvRVmTCWY9ieZPihTtFQu8bmVRLlXNIbcEXsGmptgLSrTOz9o0Pa0aKkPhE1lMFhOxrCKD2v9n-h0SdStXnb6LteE3O9815iq4VDGb3DEPCGEEobtej4Fl3FuTspSlKYf3--Ya9hJXGX6AoSRA2k","theme":"jynarque_hcp","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"google\nnonGooglePixels\nnonGoogleScripts\nnonGoogleIframes","blocklist_classes":"customScripts\ncustomPixels","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-W8LVZL2"]},"privacy_compliant_media_settings":{"enabled":1,"general":{"error_cmp_not_found":"Consent management is currently disabled, website functionality may be affected. Please try reloading the page."},"youtube":{"enabled":0,"cat_id":"C0002","dependent_cat_id":"C0004","modal":{"description":"To start your video we need your permission to use YouTube cookies. These cookies help us make other video recommendations specific to your interests.","consent_label":"Allow YouTube cookies","morelink_label":"Learn more about cookies","morelink_url":"javascript:OneTrust.ToggleInfoDisplay();"},"overlay_image":null},"vimeo":{"enabled":1,"cat_id":"C0008","dependent_cat_id":"C0004","modal":{"description":"By clicking \u0027Accept\u0027, you will enable functional cookies that are necessary for the video\u0027s playback on this platform. These cookies can be reviewed \u003Ca  href=\u0022javascript:OneTrust.ToggleInfoDisplay();\u0022\u003Ehere\u003C\/a\u003E and adjusted at any time by clicking the shield above. Want to know more? View our \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/www.otsuka-us.com\/privacy-policy\u0022\u003EPrivacy Notice\u003C\/a\u003E.\r\n\u003Ca class=\u0022otsuka-pcm-consent-link\u0022 href=\u0022javascript:OneTrust.ToggleInfoDisplay();\u0022 role=\u0022button\u0022 aria-label=\u0022Privacy Notice\u0022\u003EPrivacy Notice\u003C\/a\u003E","consent_label":"Accept","morelink_label":"","morelink_url":""},"overlay_image":null},"buzzsprout_podcasts":{"enabled":0,"cat_id":"C0002","modal":{"description":"To start your podcast we need your permission to contact Buzzsprout. This allows us to place a podcast player widget on the page.","consent_label":"Allow Buzzsprout player","morelink_label":"","morelink_url":""},"overlay_image":null},"orbita_live_chat":{"enabled":0,"cat_id":"C0002","widget":{"wrapper_id":"chatbot-wrapper","html":"\u003Cdiv class=\u0022with-default-orbita-widget\u0022\u003E\r\n  \u003Cbutton class=\u0022chat-widget\u0022 aria-label=\u0022Show Chatbot\u0022\u003E\r\n    \u003Cdiv\u003E\r\n      \u003Cdiv class=\u0022chat-bubble\u0022\u003E\u003C\/div\u003E\r\n      \u003Cp\u003EChat\u003C\/p\u003E\r\n    \u003C\/div\u003E\r\n  \u003C\/button\u003E\r\n\u003C\/div\u003E","css":""},"modal":{"description":"To open the live chat we need your permission to contact Orbita. This allows us to place a live chat widget on the page.","consent_label":"Allow Orbita live chat","morelink_label":"","morelink_url":""}}},"user":{"uid":0,"permissionsHash":"9ce7e3d0a53d6f666750a985c111fdd22308fb0fdb5f15c0fdda00c8dcaa54f4"}}</script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_dxIVcwvQ00owLGoUGPTfRYXU-T5rnj8Xi0cXfb3Kn58._JqT3SQfawRcv_BIHPThkBvs0OEvtFFmqPF_lYI_Cxod734.js?v=3.7.1"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_w0iO3No0CsyHgJmryEbhwpkh5zx6m6dhvawBt4ufwyA.HRN_m4FplP890kDvBJQuv0fEgTHDKwrMZA2zBldV1JYf700.js?v=1.0.1"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_Hpe5jrMuKXrV4HSTMApXJsNBxraAgcHUrTjxkwWKqy8.9H1W9OQqD9V27idEVOJMCFAQtGS4Scq-gAQciKr0U2Mfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_V1oRQ-kJlXBZaEklOtPUe_1t8-l0RS94HJ3gsqxKikc.LMtm7OsF5tFcpxpmBexOddu30l-Xz-FUCSBPovfiEt8fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_KRjtvzl6UujB23-j_sF6dqOcbqg2z8ej98A8RU9bGsg.kjk12BMQYgWzHTlTsh40oAfzJ1jsDD0rpt092h-M9ukfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_rJQeYB7caXNCdmgzJ4t5f6f6CrVuk9_CJlqK8yDBzqk.QLD7mKey3phzumqz3uRKIHY2nqqKo_plzIfGrgeQ5Ycfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_pbrt6BW6zk2scxcVck6pKOhrsnS-4n6mdUeoPTfK2aM.F15X2YCXNVRiXJFw9bAWTN9GXU1HaAbvYHvOoFmnbLUfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_CbOM1f2ZQjSvD29Vzs3nHYsIjSyprydKvJ38uk-EKzQ.dAXI56pV2ZPn9QGfyd-mmPdBCd_VlavLN59BjPAgNOgfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_1_Qr-HDXqlP8qV9oE0Levmwx3Sc1ldDn6Q9QvWEYY6E.XXTdDFNiWNbao5RRs1Aq-_G2fwGOGtyrrBgSr48Pr6wfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_yt_B6-UYT74y4dRKoGQ9gfLb0O0RDb4vG2LIGOYlHq8.-UGjQblMTO_e3Grk02Go8eAWHwbL6GT0oAl-h-CgK5Qfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_OYMUXIYk_UxVlsQSqo3_hSK3aC6qbx7cz9wNrtTse48.D7Do9Gn7KAOch1JHc7ma8CZHkvZvUTPAc5nIoo3LX44fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_A7R00KDzeuDMEsk6DOs_s2ZrOjO5c23zgXuffR4Khqc.q6qxxfVF7-gZME3a3JPerO2q6sv01F6mQnVPwcmknYofe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_4VhSX4lEyBg9lxgOnT6eUHtdfwq4GgGv6TSm_aWIhzc.msJZjs5u5RGmKA2fbhFxLGexUv1x2UOibCSs8rzkw1Ufe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_VycJ3FTVVaVyhSCcLXYEaSJoilQ8WxeImUFAjqgR5Y8.ouOM0Q5oYPfUBV8lTR3cCyJG56DQNwRTOVgi8IFXBrAfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_QZ6R3WHZ2xvc16JcQ7QBGg7ZW5Q69JxQSKxhelKIbIE.rnfvk6uzW1ISnGjxzePWaH83MAcUkTOsSGF6xij2QAsfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_SpWiM_QFpYbnP3qrlmV1Aa2OGQVC1G0okd3jErKS1EI.Cz8_DwPQcpJrjdTZvBKdqWS7V0abyjGDgrVg6Diy3jkfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_shtMqRNOVBaAvLi9-CpiCI1loPsDLJlEM8e0qdxIyaA._ljAZbtHeBUPsD_JTpPHK9XLnZ-Bh8IIR0gfaERLf0kfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_J05cWfCFFxc6Ntk7FqEMfp2MqvFE0LYhqPR-d5pkpX4.eRBP0BbEW9K4axpZn5GrBrvbQysogv9ziF_qly6y9P0fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_XrfmCmDqLTCEPh8gnU8hVIYf5mJPXNeZp91Zu1g8f9Y.i3qujr4t4NUUzwk0bY4rUPAZgLDWLpH4I0Ht5U7c2Gsfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_DB1pt9EyFJ14MM4u0q_UUdhcwWPwrgl0M8Ao_U1cQKw.1HGXCu8xDCZ9D4t4OUEJBVbpMoVuuCDmld0Orcde48Ufe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_xTMVqsdfgSLZsrDVnB0yeJ_u8fjPX7MQHI1nVihqNuE.7B-a0BsG-0oGVyrcfb37AxOKeNquBdl8lk3CyiHXfeUfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_gEmjNg-vrsVI816UzVFe6X3vlSx0FTpPgKUR0axgrXs.aT1b17yuuFOZ02MCX5ONYrorBiyoVdHn6EFMtlXyDCAfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_trjIfy6wGxnxz9PVSI8rA84dA6HxX_Lw5W4uUlw0Xs0.-KbTIsNarrWDUf2UHG7fElVJxl72-Pmuf_1NbApB5A0fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_2hr-YHySYMDuptPCwhH1H7CfNShEa93koPpOo_581D4.fU-RbWLSh2I8Ytqntu1-ArKZ9OVXly0tO-X8U0Ety6Ife04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_WmhavmnC0K35xZ9vLX51qtRqFT74puvZXIMWnNUYpbM.HmKlReEYCiV9GnfhxV81WuXqMJ6i6CJEQgYJrzlXRtw0559.js?v=6.2.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_pCqeI411sVqMjF7f2fKhUUOV4yKaxxQp7FHSELuxGGc.2g5bmie0CWfVbbOg32zvwXHEUfmS0mqFc0I_Z7vrtvMfe04.js?v=10.5.0"></script>
<script src="modules/contrib/adobe_launch/js/adobe_launch_dtm_init1cee.js?t5xpr9"></script>
<script src="modules/contrib/google_tag/js/gtag1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_1woVuTYaOTc9db19BvtYERQ-r3zrWbaX8Iy9t_Z2qoM.pMTBYmavvxWwegzqwJmMmmYVLsQ3cxiWBi9yq_dxzNMe0a5.js?v=4.3.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_mjv4qhOv2_1-EQeYpZwvWqHcMokP3Cu36uHh9tRNXFY.CJF84Dv0PjH3KPaqgwzS-NJS45qPbXaVePB7UAw-uH8fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_ezwJb8QjKN82W11Y2widYXtFt5DfOo-fgZxIg_9sAik.s0ftg9DcYKonxRNsyujPK8mZFoHu6DwZvsB0967odSIfe04.js?v=10.5.0"></script>
<script src="modules/contrib/google_tag/js/gtm1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/isi-state1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_J_G6YrAi5duRDJekzJ6rjnG28oqOVCu_MPQwxhSYGow.Qp9BFfZG_BWtt9YimvmtE9BSWD3fWWQmE_KLI5Eoiao1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_dgim6OgqTA_DG5wPkPdSGk_ffzUkd8ip9LwuHxVo1sI.mZ98qx_1nQtXzgDDy9reKJSzFDoo-w4yhyIdEfKAHlM1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_q7FJqCr4JCiQip_Tz2e_h4tgMP443SG2ovYc1mDfmhQ.pnyD-CkIhe1h_Jx0jtDrfSNlPJAqzILWsJ3NvZYdOtI1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_aEkVIYuSMtGvUpkRLpsx4Havd-U7CgaBzI4c8T043hY.bNn0IFRdhaUJdh1PX_eJXXz5xx_slAb_npV-mqLhAyw1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/isi-resize1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/base/bootstrap/bootstrapcd33.js?v=4.5.2" defer></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_P-oMcsV1isPQN7J_9srX5flt9fqyRhUBLJFfnVUO7_8.Uf0TeQfB8iU5YkLJufFdWdXZs7P4QlCa9W649PI35-k1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_OS7umhC2npk_k6HFrTBUOGw7IMkQkSTpjJrtCzMIIFU.mjh9oGk3WVOVcHsF6kJLjqansWN1KLh7O_3yd4FDBmg1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_bxDZKA71LpajHuuDs_IsmHcULV4iGZ5wDebNISM68Ec.QOaAi5jgG26lpVuvuNRQ1BkxXXJdSqieBPgIZrXkS9M1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/jynarque/jynarque_custom1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/mainmenu1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/anchor-scroll1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/video-react1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_nKlW0s1eP3bGjyfbSHP4guHgnuCQ2V_IbkgMZ4UdzO4.MTHCcdAQ1524jW6nLa3EtNqF_1TujsKyr8qksEY7n6wfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_KKcnkUdYKB53TMNVsf6RrHXCgsIpqtdkf2utxTGblLc.ynu_A6j2Wzd1B6Vw6BTQ8qyocstdbrEa04BlYLcbHiEfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_3V5UYvHeGVCTCI6-0G9MShZMkOTjpmWzauUa17REJYg.Skr0Jc5GUKefc-pdZvCEo932Y2orIBO4a5uHTzer7YMfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_7SLROedAOygMVqhG50yRRbiZ1w7AmAy9Wx63Se_hrEo.RHHoh3qOJXKfC_izkCzBQeHAM9lKs2tMLnwwXJQddecfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_3PPDECkkWmZprRXP5fGfqH5tOkTJcwB21__r7fjPUh4.FM0QEgk5sXswUR2j_HZSngwH1zEUr0v2J8mHf-3nglsfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_GrQl3TMVBdSFgif7bkvIVoCWbf9SY3sm8jianc5MBYI.a7xJmtDE8RvIy3x-q9FvAIJ1W6CbYZd3rd0FQNL3Q-sfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_4bZGp8eSSkr0AcYEB06FWt2zMZLqDhKxz6gEhKnO5X0.-_wJjs2BWnIoDstNCjVUMdohPAm1Cb6KMFLzNQnyetsfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_dOdL6MKe8Xi7Kps6emaAgxWRpDXYc7U7glpIUKIBOiA.XAp-Kcb5FZvnj1DJvOdVsSEE04SX1ckhOvPcQwTj6hofe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_YSBqDrGfkyMrsn-wT-lty4BnE7uEji7vl0zKC_-Z0BE.oLTnTHb9AUCZyGIMu_xYoE6Miz_LA_c24mSOzHiEwxUfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js__TF0_87cNnB7zfFuH5jalW1RMKzKj__FtRNXnDln7eA.LbmYeeNvT-Bo1K2wExK2EJO_Hm8zkO7p3Daf1NdLzbMfe04.js?v=10.5.0"></script>

  </head>
  
  <body class="isi-enabled isi-drawer-enabled custom-page--patient-identification section--0-identify-patients path-node page-node-type-internal-page page-node-38836">
    <div class="content-wrapper">
        <div role="navigation" aria-label="Skip to main content">
      <a href="#main-content" class="visually-hidden focusable skip-link">
        Skip to main content
      </a>
    </div>
    
<header role="banner" id="header-wrap" class="menu-section">
    <div class="header-container">
      <div class="header-left">
        <div class="header-branding">
          <a href="index.html" data-test="navbar-logo" 
            data-analytics-link='{"name":"company logo","position":"header","group":"Logo","href":"https://www.jynarquehcp.com/"}' 
          ><img src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/img/jynarque-logo.png" alt="JYNARQUE® (tolvaptan), Logo"></a>
        </div>
        <a href="#" class="off-canvas-button" 
          data-analytics-link='{"name":"Navbar Toggle","position":"header","group":"Logo","href":"https://www.jynarquehcp.com/"}' 
          data-test='mobile-menu-toggle'
        ></a>
      </div>
      <div class="header-right">
        <div class="header-intended-audience">
            <div class="region region-header-intended-audience">
    <nav role="navigation" aria-labelledby="block-utilitynav-menu" id="block-utilitynav" class="custom-block--utilitynav">
            
  <div class="visually-hidden" id="block-utilitynav-menu">Utility Nav</div>
  

        
              <ul block="block-utilitynav" region="header_intended_audience" data-test="top-menu">
              <li>
                <a href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank" class="ssp-bold mobile-separator prominent reverse-yellow mobile-shift external-link-popup-disabled">U.S. FULL PRESCRIBING INFORMATION,<br /> INCLUDING BOXED WARNING</a>
              </li>
          <li>
                <a href="#isi-top" target="_self" class="isi-jump-link ssp-bold prominent important-safety-information-link">Important Safety Information</a>
              </li>
          <li>
                <a href="https://www.jynarque.com/" target="_self" class="ssp-bold mobile-hide ext-link prominent patient-site-link ssp-bold mobile-hide ext-link prominent patient-site-link">Patient Site</a>
              </li>
          <li>
                <span>This site is intended for U.S. Healthcare Professionals only</span>
              </li>
        </ul>
  


  </nav>

  </div>

        </div>
        <div class="header-main-menu">
            <div class="region region-header-main-menu">
    <nav role="navigation" aria-labelledby="block-jynarque-hcp-main-menu-menu" id="block-jynarque-hcp-main-menu" class="custom-block--jynarque-hcp-main-menu">
            
  <div class="visually-hidden" id="block-jynarque-hcp-main-menu-menu">Main navigation</div>
  

        

              <ul block="block-jynarque-hcp-main-menu" region="header_main_menu" class="menu nav" data-test='main-menu'>
                          <li class="menu-item">
                                                            <a href="index.html" class="home-link" data-analytics-link="{&quot;name&quot;:&quot;Home&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/&quot;}" data-drupal-link-system-path="&lt;front&gt;">Home</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span target="_self" class="understanding-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Understanding ADPKD&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Understanding ADPKD</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="adpkd/about.html" data-analytics-link="{&quot;name&quot;:&quot;About ADPKD&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/adpkd/about&quot;}" data-drupal-link-system-path="node/25846">About ADPKD</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="adpkd/progression.html" target="_self" data-analytics-link="{&quot;name&quot;:&quot;Disease progression&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/adpkd/progression&quot;}" data-drupal-link-system-path="node/2">Disease progression</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="measuring-tkv-for-ckd-staging.html" data-analytics-link="{&quot;name&quot;:&quot;Measuring kidney size&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/measuring-tkv-for-ckd-staging&quot;}" data-drupal-link-system-path="node/9">Measuring kidney size</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="mechanism-of-action.html" class="mechanism-of-action-link nav-desktop-only" data-analytics-link="{&quot;name&quot;:&quot;Mechanism of Action&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/mechanism-of-action&quot;}" data-drupal-link-system-path="node/4">Mechanism of Action</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span class="efficacy-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Efficacy&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Efficacy</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="clinical-trial-efficacy.html" data-analytics-link="{&quot;name&quot;:&quot;Pivotal trials&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-trial-efficacy&quot;}" data-drupal-link-system-path="node/25991">Pivotal trials</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="non-pivotal-data.html" data-analytics-link="{&quot;name&quot;:&quot;Non-pivotal data&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/non-pivotal-data&quot;}" data-drupal-link-system-path="node/26061">Non-pivotal data</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span target="_self" class="safety-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Safety Profile&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Safety Profile</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="clinical-information/safety-profile.html" data-analytics-link="{&quot;name&quot;:&quot;Safety profile&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-information/safety-profile&quot;}" data-drupal-link-system-path="node/5">Safety profile</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="clinical-information/open-label-extension-study.html" data-analytics-link="{&quot;name&quot;:&quot;Open-label extension study&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-information/open-label-extension-study&quot;}" data-drupal-link-system-path="node/26066">Open-label extension study</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="rems-program.html" class="rems-link" data-analytics-link="{&quot;name&quot;:&quot;REMS&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/rems-program&quot;}" data-drupal-link-system-path="node/7">REMS</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--expanded menu-item--active-trail">
                                                            <span class="identifying-counseling-patients-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Identifying and Counseling Patients&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Identifying and Counseling Patients</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item menu-item--active-trail">
                                                            <a href="identify-patients.html" data-analytics-link="{&quot;name&quot;:&quot;Patient identification&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}" data-drupal-link-system-path="node/38836" class="is-active" aria-current="page">Patient identification</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="patient-profiles.html" data-analytics-link="{&quot;name&quot;:&quot;Patient profiles&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/patient-profiles&quot;}" data-drupal-link-system-path="node/26016">Patient profiles</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="patient-counseling.html" class="patient-counseling-link Patient Counseling" data-analytics-link="{&quot;name&quot;:&quot;Patient counseling&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/patient-counseling&quot;}" data-drupal-link-system-path="node/38851">Patient counseling</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
                      <li class="menu-item">
                                                            <a href="dosing-information.html" class="dosing-link nav-desktop-only" data-analytics-link="{&quot;name&quot;:&quot;Dosing&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/dosing-information&quot;}" data-drupal-link-system-path="node/6">Dosing</a>
        
        
        
        
              </li>
                      <li class="menu-item menu-item--collapsed">
                                                            <span class="resources-link data-analytics-click-link" role="button" data-analytics-link="{&quot;name&quot;:&quot;Resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;n/a&quot;}">Resources</span>
        
        
                  <div class="menu-toggle"></div>
        
        
                                <ul class="menu sub-nav">
                          <li class="menu-item">
                                                            <a href="expert-videos.html" data-analytics-link="{&quot;name&quot;:&quot;Video library&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/expert-videos&quot;}" data-drupal-link-system-path="node/38816">Video library</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="treatment-resources.html" data-analytics-link="{&quot;name&quot;:&quot;Treatment resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/treatment-resources&quot;}" data-drupal-link-system-path="node/38831">Treatment resources</a>
        
        
        
        
              </li>
                      <li class="menu-item">
                                                            <a href="clinical-resources.html" data-analytics-link="{&quot;name&quot;:&quot;Clinical resources&quot;,&quot;position&quot;:&quot;header&quot;,&quot;group&quot;:&quot;main-menu&quot;,&quot;href&quot;:&quot;https://www.jynarquehcp.com/clinical-resources&quot;}" data-drupal-link-system-path="node/38826">Clinical resources</a>
        
        
        
        
              </li>
        </ul>
  
              </li>
        </ul>
  


  </nav>

  </div>

        </div>
      </div>
    </div>
</header>

    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W8LVZL2"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    <div  class="layout-container" >

  
    <div class="region region-messages">
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>


  <main role="main">
    <a id="main-content" tabindex="-1"></a>
          <div class="layout-pre-content">
          <div class="region region-pre-content">
    <div class="views-element-container custom-block--views-block__custom-page-title-custom-page-title" id="block-views-block-custom-page-title-custom-page-title">
  
    
      <div><div class="js-view-dom-id-1488c13842aa33cb20cfc27eeaa47eb1bd6291a7fb33ab5896b9d23b725a2f56">
  
  
  

  
  
  

      <div class="views-row"><div class="views-field views-field-field-headline"><h1 class="field-content page-title">With ADPKD, there is a lot to consider</h1></div></div>

    

  
  

  
  
</div>
</div>

  </div>

  </div>

      </div>
    
    <div class="layout-content content-wrap-outer">
          <div class="region region-content">
    <div id="block-jynarque-hcp-content" class="custom-block--jynarque-hcp-content">
  
    
      
<article class="custom--patient-identification right-sidebar-region-full">
  <section class="node-wrapper">
    
    
    <div class="container">
      <div class="row">
                  <div class="col-md-10 col-lg-7">
            <div class="node-content">
              


                    


      
    
    
    
    
    
    
                


<div  class="image-text-block image-text-block--image-top clearfix" data-test="paragraph">
                        


<h3  class="image-text-block__heading">
      Patients with stable eGFR could be at risk of rapid progression<sup>1,2</sup>
  </h3>
          
        <div  class="image-text-block__content">
      <div  class="image-text-block__image-wrapper">
                                      

  
<img
   class="image-text-block__image d-none d-lg-block"
      src="sites/g/files/qhldwo11641/files/2025-03/stable-egfr-vs-declining-egfr-graph.jpg"
      alt="Stable eGFR vs. Rapidly Declining eGFR, Graph"
           alt="Stable eGFR vs. Rapidly Declining eGFR, Graph" width="1180" height="578" loading="lazy"
  />
                  
                                      

  
<img
   class="image-text-block__image d-block d-lg-none"
      src="sites/g/files/qhldwo11641/files/2025-03/stable-egfr-vs-declining-egfr-graph-m.jpg"
      alt="Stable eGFR vs. Rapidly Declining eGFR, Graph"
           alt="Stable eGFR vs. Rapidly Declining eGFR, Graph" width="780" height="608" loading="lazy"
  />
                        </div>

                              
<div
   class="image-text-block__body"
  >
      <p class="footnote mb-3 mb-lg-0">ADPKD=autosomal dominant polycystic kidney disease; eGFR=estimated glomerular filtration rate. <span class="d-lg-block mt-lg-2">KDIGO=Kidney Disease: Improving Global Outcomes.</span></p>
  </div>
                  </div>
  </div>
    
    
  
                              


      
    
    
    
    
    
    
                



        
  
<div  id="paragraph-6821" data-test="accordion" data-analytics-group="Accordion" class="accordion accordion container  ">
      
                  


<h2  class="accordion__title">
      Measuring eGFR alone doesn't always reveal how ADPKD is progressing<sup>1</sup>
  </h2>
          
                            <div  class="accordion-item accordion-item--stable-egfr accordion-item--1"  data-item-number="1" data-test='accordion-item'>

                        


<h2  class="accordion-header" id="headingparagraph-68210" data-test="accordion-header">
                



<button  type="button" data-bs-toggle="collapse" data-bs-target="#collapseparagraph-68210" aria-expanded="true" aria-controls="collapseparagraph-68210" class="accordion-button  "                                 >
                
<span
   class="title"
  >
      Stable eGFR
  </span>
          
<span
   class="subtitle"
  >
      
  </span>
        
  </button>
        
  </h2>
                <div id="collapseparagraph-68210"
           class="collapse accordion-collapse show"
             role="region"
             aria-labelledby="headingparagraph-68210"
           data-test='accordion-content'>

          <div  class="accordion-body">

            
            
            
            
            
            
            
                          



<div  class="image-text-block image-text-block--image-top" data-test="paragraph">
                        


<h3  class="image-text-block__heading">
      Kidney growth and damage often occur before kidney function declines<sup>1,3,5</sup>
  </h3>
          
        <div  class="image-text-block__content">
      <div  class="image-text-block__image-wrapper">
                                      

  
<img
   class="image-text-block__image d-none d-lg-block"
      src="sites/g/files/qhldwo11641/files/2025-03/functions-vs-size-over-time-graph.png"
      alt="Kidney Function vs. Kidney Size Over Time, Graph"
           alt="Kidney Function vs. Kidney Size Over Time, Graph" width="1176" height="642" loading="lazy"
  />
                  
                                      

  
<img
   class="image-text-block__image d-block d-lg-none"
      src="sites/g/files/qhldwo11641/files/2025-03/functions-vs-size-over-time-graph.png"
      alt="Kidney Function vs. Kidney Size Over Time, Graph"
           alt="Kidney Function vs. Kidney Size Over Time, Graph" width="1176" height="642" loading="lazy"
  />
                        </div>

                              </div>
  </div>
            
                          <div id="block-legacy2stepriskidentification" class="custom-block--legacy2stepriskidentification block-content-legacy-2-step-risk-identification block-content-paragraph-block">
  
    
      


                    <div class="field_paragraph ">
  <div class="clearfix paragraph paragraph--type--from-library paragraph--view-mode--default" id="paragraph-7506" data-test='paragraph'>
          


                    <div class="paragraphs ">
  <div class="custom-full-width-tabs custom-wrapper-type-tabbed clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7501" data-test='paragraph'>
          


                    <div class="field_title "><h2 class="mt-0 pt-0">2-step risk identification can help determine if JYNARQUE is appropriate for your patients whose eGFR appears stable</h2></div>
            

  <div class="field--name-field-paragraphs container tabs-container" data-test="tabs" data-analytics-group="Tabs">
    <ul class="nav nav-tabs" id="tablist-1591944381" role="tablist">
              <li class="nav-item">
          <a class="nav-link active"
             id="paragraph-7456-tab"
             data-toggle="tab"
             href="#paragraph-7456"
             aria-selected="true"
             data-test="tabs-item"
          >
            Step 1: <br class="d-lg-none">Identify Risk Factors
          </a>
        </li>
              <li class="nav-item">
          <a class="nav-link"
             id="paragraph-7496-tab"
             data-toggle="tab"
             href="#paragraph-7496"
             aria-selected="false"
             data-test="tabs-item"
          >
            Step 2: <br class="d-lg-none">Measure Kidneys
          </a>
        </li>
          </ul>
    <div class="tab-content" id="tablist-1591944381-content">
              <div class="accordion-item mobile">
          <a
            class="active"
            data-tab-id="paragraph-7456-tab"
            data-test="tabs-item"
          >
            Step 1: <br class="d-lg-none">Identify Risk Factors
          </a>
        </div>
        <div class="tab-pane fade show active"
             id="paragraph-7456"
             role="tabpanel"
             data-tab-key="0"
             aria-labelledby="paragraph-7456-tab"
             data-test="tabs-content"
        >
          
  <div class="clearfix paragraph paragraph--type--wrapper-tab-item paragraph--view-mode--default" id="paragraph-7456" data-test='paragraph'>
          


                    <div class="field_body "><h3>Even when eGFR appears normal, irreversible kidney damage may<br class="d-none d-lg-inline">
still be occurring<sup>1,2</sup></h3>

<h4>Patients presenting with any of these independently validated risk factors could be experiencing rapid ADPKD progression<sup>6</sup></h4>
</div>
            


                    <div class="field_paragraphs ">
  <div class="custom-3col-grid clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7446" data-test='paragraph'>
            <div class="container">
    <div class="row">
              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7366" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/pdk1-mutation-icon.png" width="196" height="195" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Truncating <em>PKD1</em> <br>
mutation<sup>7</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7381" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/overweight-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Overweight and obesity<br>
(BMI ≥25 kg/m<sup>2</sup>)<sup>8</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7396" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/hypertension-before-35-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Hypertension before <br>
age 35<sup>7</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7411" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/urologic-events-before-35-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Urologic events before <br>
age 35 (gross hematuria,<br>
cyst infection, or flank pain related to cysts)<sup>7</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7426" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/proteinuria-and-microalbuminuria-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Proteinuria and<br>
microalbuminuria<sup>6</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

              
  <div class="clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7441" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/family-history-of-eskd-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Family history of ESKD <br>
at or before age 58<sup>4</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>

          </div>
  </div>

      </div>
</div>
                              <div class="field_paragraphs ">


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p class="caption small mr-n3">ADPKD=autosomal dominant polycystic kidney disease;<br class="d-lg-none">
BMI=body mass index; eGFR=estimated glomerular filtration rate;<br class="d-lg-none">
ESKD=end-stage kidney disease.</p>
</div>
            
    
  </div>
            
      </div>

        </div>
              <div class="accordion-item mobile">
          <a
            class=""
            data-tab-id="paragraph-7496-tab"
            data-test="tabs-item"
          >
            Step 2: <br class="d-lg-none">Measure Kidneys
          </a>
        </div>
        <div class="tab-pane fade"
             id="paragraph-7496"
             role="tabpanel"
             data-tab-key="1"
             aria-labelledby="paragraph-7496-tab"
             data-test="tabs-content"
        >
          
  <div class="clearfix paragraph paragraph--type--wrapper-tab-item paragraph--view-mode--default" id="paragraph-7496" data-test='paragraph'>
          


                    <div class="field_body "><h3>If at least <span class="fw-black">ONE</span> risk factor is identified,<br class="d-lg-none">
a kidney measurement should be ordered</h3>

<p><strong>Why it’s important to obtain a kidney measurement</strong></p>
</div>
            


                    <div class="field_paragraphs ">
  <div class="custom-image-with-text clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7471" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/kidney-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>Kidney size is a strong predictor of ADPKD progression before eGFR begins to decline<sup>9</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>
</div>
                              <div class="field_paragraphs ">
  <div class="custom-image-with-text clearfix paragraph paragraph--type--wrapper paragraph--view-mode--default" id="paragraph-7486" data-test='paragraph'>
            <div class="container">
    <div class="row">
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_image "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2024-07/kidney-measurement-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    
  
              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p>A CRISP cohort analysis, published in <em>Kidney International</em>, showed that a one-time TKV measurement can help assess the rate of future kidney function decline<sup>10</sup></p>
</div>
            
    
  
          </div>
  </div>

      </div>
</div>
                              <div class="field_paragraphs ">


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p><strong>When requesting kidney measurements, ask the radiologist for:</strong></p>

<ul>
	<li>Maximal bilateral kidney dimensions (L x W x D)</li>
	<li class="separator"><strong>and/or</strong></li>
	<li>A calculated TKV</li>
</ul>

<p><strong>When you receive measurements:</strong></p>

<ul>
	<li>Plot TKV on the <a class="ext-link cyan" href="https://qxmd.com/calculate/calculator_490/total-kidney-volume-height-adjusted-calculator-adpkd-prognostic-tool-using-kidney-dimensions?++branch_match_id=9080583+02213126030&amp;_branch_refer+rer=H4sIAAAAAAAAA8soKS+kottLXL6xITsxJ1kssKNDLycz+L1vdNrMz3dgEAsfozlB4AAA+A%3D" rel=" noopener" target="_blank">Mayo Imaging Classification tool</a> to determine the risk of progression and appropriateness for treatment<sup>11</sup></li>
</ul>

<p class="caption small mr-lg-n3 mb-2">L=length; W=width; D=depth.</p>

<p class="caption small mr-lg-n3 mt-0">ADPKD=autosomal dominant polycystic kidney disease;<br class="d-lg-none">
eGFR=estimated glomerular filtration rate;<br class="d-none d-lg-inline">
TKV=total kidney volume.</p>
</div>
            
    
  </div>
            
      </div>

        </div>
          </div>
  </div>

      </div>
</div>
            
      </div>
</div>
            
  </div>

            
            
            
                          



        
  
<div  data-test="paragraph" class="video-single">
                    


<h3  class="video-single__heading">
      Treating patients with ADPKD when kidney function appears stable
  </h3>
              <div class="video-wrapper">
                        

        
  
<div  class="videoReact">
      <div  class="videoReact__wrapper" id="videoReact-6821-0" data-analytics-group='Video'>
      <div class="thumbnail play-video">
        
<img
   class="thumbnail-image position-absolute"
      src="sites/g/files/qhldwo11641/files/2024-05/treating-patients-when-kidney-function-stable-video.jpg"
      alt="Treating Patients When Kidney Function Appears Stable, Video"
      />
        <div class="play-button play-video" tabindex="0">
          <button class="icon">Play</button>
        </div>
      </div>
      <div class="react-player-video" data-url="https://vimeo.com/1084273854"></div>
    </div>
  </div>
                  </div>
  </div>
            
                      </div>
        </div>
      </div>
                            <div  class="accordion-item accordion-item--rapidly-declining-egfr accordion-item--2"  data-item-number="2" data-test='accordion-item'>

                        


<h2  class="accordion-header" id="headingparagraph-68211" data-test="accordion-header">
                



<button  type="button" data-bs-toggle="collapse" data-bs-target="#collapseparagraph-68211" aria-expanded="false" aria-controls="collapseparagraph-68211" class="accordion-button collapsed"                                 >
                
<span
   class="title"
  >
      Rapidly declining eGFR
  </span>
          
<span
   class="subtitle"
  >
      
  </span>
        
  </button>
        
  </h2>
                <div id="collapseparagraph-68211"
           class="collapse accordion-collapse"
             role="region"
             aria-labelledby="headingparagraph-68211"
           data-test='accordion-content'>

          <div  class="accordion-body">

            
            
            
            
            
            
            
                          



<div  class="image-text-block image-text-block--image-top" data-test="paragraph">
                        


<h3  class="image-text-block__heading">
      Rapidly declining eGFR means the risk of ADPKD progression is fully realized<sup>3,4</sup>
  </h3>
          
        <div  class="image-text-block__content">
      <div  class="image-text-block__image-wrapper">
                                      

  
<img
   class="image-text-block__image d-none d-lg-block"
      src="sites/g/files/qhldwo11641/files/2025-03/functions-vs-size-over-time-graph-end.png"
      alt="Kidney Function vs. Kidney Size Over Time, Graph"
           alt="Kidney Function vs. Kidney Size Over Time, Graph" width="1176" height="602" loading="lazy"
  />
                  
                                      

  
<img
   class="image-text-block__image d-block d-lg-none"
      src="sites/g/files/qhldwo11641/files/2025-03/functions-vs-size-over-time-graph-end.png"
      alt="Kidney Function vs. Kidney Size Over Time, Graph"
           alt="Kidney Function vs. Kidney Size Over Time, Graph" width="1176" height="602" loading="lazy"
  />
                        </div>

                              
<div
   class="image-text-block__body"
  >
      <p class="footnote-lg">Historical annual eGFR decline of ≥3 mL/min/1.73 m<sup>2</sup> (determined by multiple measurements of eGFR over 3–5 years).<sup>12</sup></p>
  </div>
                  </div>
  </div>
            
            
                                          


<div  class="card-h center-mobile type-a" data-test='card'>
    
    <div  class="card-h__content">
                                  <div  class="card-h__image-block card-h__image-block--">
            
<img
   class="image"
      src="sites/g/files/qhldwo11641/files/2025-06/check-mark-icon.svg"
           width="" height="" loading="lazy"
  />
          </div>
              
                    
<div
   class="card-h__body"
  >
      <h3>If your patients are showing evidence of rapidly progressing ADPKD, consider whether JYNARQUE may be an appropriate treatment choice.</h3>
  </div>
            </div>
</div>
                          
            
                          



        
  
<div  data-test="paragraph" class="video-single">
                    


<h3  class="video-single__heading">
      Treating patients with rapidly declining eGFR
  </h3>
              <div class="video-wrapper">
                        

        
  
<div  class="videoReact">
      <div  class="videoReact__wrapper" id="videoReact-6821-1" data-analytics-group='Video'>
      <div class="thumbnail play-video">
        
<img
   class="thumbnail-image position-absolute"
      src="sites/g/files/qhldwo11641/files/2024-05/treating-patients-with-rapidly-declining-egfr-video.jpg"
      alt="Treating Patients with rapidly declining eGFR, Video"
      />
        <div class="play-button play-video" tabindex="0">
          <button class="icon">Play</button>
        </div>
      </div>
      <div class="react-player-video" data-url="https://vimeo.com/1084273877"></div>
    </div>
  </div>
                  </div>
  </div>
            
                      </div>
        </div>
      </div>
      </div>
    
    
  
                              


      
    
    
    
    
    
    
          


                    <div class="field_otsk_ds_text "><p class="page-footnote"><span class="asterisk">*</span>eGFR ≥25 mL/min/1.73 m<sup>2</sup> and Mayo Imaging Classification 1C to 1E, or historical rate of eGFR decline of <span class="text-nowrap">≥3 mL/min/1.73 m<sup>2</sup></span> per year.</p></div>
            
    
  
            
              


                    <div class="field_component_references ">    <div class="clearfix paragraph paragraph--type--collapsible-references paragraph--view-mode--default" data-test="reference">
          <p>
        <a 
          aria-controls="collapse-references" aria-expanded="false" data-toggle="collapse" href="#collapse-references"
          data-analytics-link='{"name":"References","position":"body","group":"References","href":"n/a"}'
        >
          References
        </a>
      </p>
      <div class="collapse" id="collapse-references">
        <ol><li>Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. <em>Clin&nbsp;J&nbsp;Am&nbsp;Soc Nephrol.</em> 2006;1(1):148-157.</li><li>Grantham JJ, Torres VE, Chapman AB, et al. Volume progression in polycystic kidney disease. <em>N Engl J Med.</em> 2006;354(20):2122-2130.</li><li>Gansevoort RT, Arici M, Benzing T, et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. <em>Nephrol Dial Transplant. </em>2016;31(3):337-348.</li><li>Müller RU, Messchendorp AL, Birn H, et al. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. <em>Nephrol&nbsp;Dial&nbsp;Transplant.</em> 2022;37(5):825-839.</li><li>Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. <em>Nat Rev Nephrol.</em> 2011;7(10):556-566.</li><li>Rastogi A, Ameen KM, Al-Baghdadi M, et al. Autosomal dominant polycystic kidney disease: updated perspectives. <em>Ther Clin Risk Manag.</em> 2019;15:1041-1052.</li><li>Cornec-Le Gall E, Audrézet MP, Rousseau A, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. <em>J&nbsp;Am&nbsp;Soc&nbsp;Nephrol.</em> 2016;27(3):942-951.</li><li>Nowak K, You Z, Gitomer B, et al. Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease. <em>J Am Soc Nephrol.</em> 2018;29(2):571-578.</li><li>Bhutani H, Smith V, Rahbari-Oskoui F, et al; for the CRISP Investigators. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. <em>Kidney Int.</em> 2015;88(1):146-151.</li><li>Yu ASL, Shen C, Landsittel DP, et al; for the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. <em>Kidney Int.</em> 2019;95(5):1253-1261.</li><li>Magistroni R, Corsi C, Martí T, Torra R. A review of the imaging techniques for measuring kidney and cyst volume in establishing autosomal dominant polycystic kidney disease progression. <em>Am J Nephrol.</em> 2018;48:67-78.</li><li>Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD). <em>Kidney Int.</em> 2025;107(suppl 2S):S1-S239.</li></ol>
      </div>
      </div>
</div>
            
            </div>
          </div>
          <div class="col-md-10 col-lg-3">
            


                    <div class="field_sidebar_cta ">



  
  
  
      
  
            
  <div class="custom--cta-kdigo cta-box cta-box_right-side cta-type-type1" data-test='card' data-analytics-group="Call to action">
    <div class="cta-icon">
      
      


                    <div class="field_cta_media_icon "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2025-02/notebook-icon.svg" alt="" />

</div>
            
</div>
</div>
            
    </div>
    <div class="cta-body">
      


                    <div class="field_cta_body "><p>KDIGO's first-ever ADPKD-specific guideline recommends tolvaptan for&nbsp;adult patients at risk of rapid disease progression<sup>12,</sup>*</p></div>
            
    </div>
          <div class="cta-link">
        <a class="button  external-link-popup-disabled" id="cta-65046" href="https://kdigo.org/wp-content/uploads/2025/01/KDIGO-2025-ADPKD-Guideline.pdf" target="_blank">
          SEE THE GUIDELINE
        </a>
      </div>
              <div class="cta-link">
        
      </div>
      </div>
  
</div>
                              <div class="field_sidebar_cta ">



  
  
  
      
  
  
  <div class="custom--supporting-information cta-box cta-box_right-side cta-type-type1" data-test='card' data-analytics-group="Call to action">
    <div class="cta-icon">
      
      


                    <div class="field_cta_media_icon "><div>
  
  


                    <div class="field_media_image ">  <img loading="lazy" src="sites/g/files/qhldwo11641/files/2023-11/cursor-icon.png" width="41" height="39" alt="" />

</div>
            
</div>
</div>
            
    </div>
    <div class="cta-body">
      


                    <div class="field_cta_body "><p>Supporting information</p>

<p><a href="clinical-trial-efficacy.html">Pivotal Trial Data</a></p>

<p><a href="clinical-information/safety-profile.html">Full Safety Data</a></p>

<p><a href="patient-profiles.html">Patient Profiles</a></p>

<p><a href="patient-counseling.html">Patient Counseling Tips</a></p>
</div>
            
    </div>
              <div class="cta-link">
        
      </div>
      </div>
  
</div>
            
          </div>
              </div>
    </div>
  </section>
</article>

  </div>

  </div>

    </div>          <div class="layout-post-content">
          <div class="region region-post-content">
    


	<a id="isi-top" name="isi-top"></a>
	<section id="inline-isi-wrapper" class="section isi-section" data-test="isi">
		
		<div class="isi isi-block">
			<div class="isi-inline-title-wrap"><span class="isi-block-title"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</span></div>
			
      <div class="isi-inline-inner-wrap"><p class="subtitle subtitle-blue"><span class="nobr">JYNARQUE</span> is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).</p><div class="fake-box"><p class="box-title mobile-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><p class="center box-title desktop-only tablet-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><ul><li><span class="nobr"><strong>JYNARQUE<sup>®</sup> (tolvaptan)</strong></span><strong> can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported</strong></li><li><strong>Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3&nbsp;months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of&nbsp;hepatic injury can mitigate, but not eliminate, the risk of&nbsp;serious hepatotoxicity</strong></li><li><strong>Because of the risks of serious liver injury, </strong><span class="nobr"><strong>JYNARQUE</strong></span><strong> is available only through a Risk Evaluation and Mitigation Strategy program called the Tolvaptan for ADPKD Shared System REMS</strong></li></ul></div><p class="subtitle"><strong>CONTRAINDICATIONS:</strong></p><ul><li>History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease</li><li>Taking strong CYP3A inhibitors</li><li>With uncorrected abnormal blood sodium concentrations</li><li>Unable to sense or respond to thirst</li><li>Hypovolemia</li><li>Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product</li><li>Uncorrected urinary outflow obstruction</li><li>Anuria</li></ul><p><strong>Serious Liver Injury:</strong> JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD&nbsp;experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.</p><p><strong>Hypernatremia, Dehydration and Hypovolemia:</strong> JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.</p><p><strong>Inhibitors of CYP3A:</strong> Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE.</p><p><strong>Adverse Reactions:</strong> Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia.</p><p><strong>Other Drug Interactions:</strong></p><ul><li><strong>Strong CYP3A Inducers:</strong> Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers</li><li><span class="nobr"><strong>V<sub>2</sub>-Receptor Agonist:</strong></span> Tolvaptan interferes with the <span class="nobr">V<sub>2</sub>-agonist</span> activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a <span class="nobr">V<sub>2</sub>-agonist</span></li></ul><p><strong>Pregnancy and Lactation:</strong> Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy. Advise women not to breastfeed during treatment with JYNARQUE.</p><p class="reporting">To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at <span class="nobr">1-800-438-9927</span> or FDA at <span class="nobr">1-800-FDA-1088</span> (<a class="cyan ext-link" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program">www.fda.gov/medwatch</a>).</p><p class="pb-2">Please see <a class="cyan external-link-popup-disabled" href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>.</p>
</div>
		</div>

	</section>

  </div>

      </div>
      </main>

</div>
    
<div id="interstitial-wrapper" class="interstitial-hidden">
  <div id="overlay-mask"></div>
  <div id="interstitial">
    <div class="interstitial-content-wrap-outer">
    <div class="interstitial-content-wrap-inner">
      <div class="interstitial primary-interstitial">
          <div class="region region-interstitial">
    <div id="block-interstitial" class="custom-block--interstitial block-content-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-instruction"><strong>Click "I Agree" to proceed.</strong></p>
</div>
            
  </div>

  </div>

        <a href="#" id="accept-exit" class="button external-link-popup-disabled">I Agree</a>
      </div>
            <div class="interstitial otsuka-interstitial">
          <div class="region region-interstitialotsuka">
    <div id="block-otsukapropertyinterstitial" class="custom-block--otsukapropertyinterstitial block-content-otsuka-property-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-copy">The website you are linking to is neither owned nor controlled by Otsuka America Pharmaceutical, Inc. (Otsuka).</p>

<p class="interstitial-copy">Otsuka is not responsible for the content or services on the site.</p>

<p class="interstitial-copy">The reprint you are linking to may include information that is not contained in the product labeling. Please see the <a href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>, for complete product information.</p>

<p class="interstitial-copy">Click "Ok" to proceed or "Cancel" to return.</p>
</div>
            
  </div>

  </div>

        <a href="#" id="acceptotsuka" class="button external-link-popup-disabled">OK</a>
        <a href="#" id="cancelotsuka" class="button-transparent cancel-button">CANCEL</a>
      </div>
                  <div class="interstitial iassist-interstitial">
            <div class="region region-interstitialassist">
    <div id="block-iassistpartyinterstitialoverlay" class="custom-block--iassistpartyinterstitialoverlay block-content-iassist-party-interstitial-overlay block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">Please ask your specialty pharmacy about the JYNARQUE Copay Support Program.</p>
</div>
            
  </div>

  </div>

      </div>
                  <div class="interstitial thirdparty-interstitial">
            <div class="region region-interstitial3p">
    <div id="block-3rdpartyinterstitial" class="custom-block---rdpartyinterstitial block-content-3rd-party-interstitial block-content-basic-block">
  
    
      


                    <div class="body "><p class="interstitial-opener">You are now leaving</p>

<p class="interstitial-domain">JYNARQUEHCP.COM</p>

<p class="interstitial-copy">Please be aware that Otsuka is not responsible for the content on the external website you are about to enter.</p>
</div>
            
  </div>

  </div>

          <a href="#" id="accept3p" class="button external-link-popup-disabled">OK</a>
          <a href="#" id="cancel3p" class="button-transparent cancel-button">CANCEL</a>
      </div>
          </div>
    </div>
  <button id="interstitial-close">Cancel</button>
  </div>
</div>

  </div>

    







<section id="drawer-isi" class="isi-tray jsIsiContainer isi-drawer-expanded resizing">

	<!--<div id="isi-drawer-wrapper" class="isi-drawer-collapsed">-->

    <div class="isi-header">
        <div class="isi-header-wrap">
            <div class="drawer-title"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</div>
            <button class="isi-btn jsIsiMinimize" data-oapigtmcategory="Button Clicks" data-oapigtmaction="ISI" data-oapigtmlabel="SEE MORE">
              <span class="jsSwapText jsSwapTextExpand hide">SEE MORE</span>
              <span class="jsSwapText jsSwapTextCollapse">MINIMIZE</span>
              <span class="isi-btn-icon"></span>
            </button>
        </div>
    </div>
	
	<div class="isi isi-block isi-drawer-content isi-content-wrap">
		<div class="jcf-scrollable jcf-container mCustomScrollbar">
      <div class="isi-drawer-content-heading"><h2>INDICATION and IMPORTANT SAFETY INFORMATION</h2>
</div>
      <p class="subtitle subtitle-blue"><span class="nobr">JYNARQUE</span> is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).</p><div class="fake-box"><p class="box-title mobile-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><p class="center box-title desktop-only tablet-only subtitle-blue"><strong>WARNING: RISK OF SERIOUS LIVER INJURY</strong></p><ul><li class="jsIsiVisible-mob"><span class="nobr"><strong>JYNARQUE<sup>®</sup> (tolvaptan)</strong></span><strong> can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported</strong></li><li class="jsIsiVisible-dt"><strong>Measure transaminases (ALT, AST) and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3 months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of&nbsp;hepatic injury can mitigate, but not eliminate, the risk of serious hepatotoxicity</strong></li><li><strong>Because of the risks of serious liver injury, </strong><span class="nobr"><strong>JYNARQUE</strong></span><strong> is available only through a Risk Evaluation and Mitigation Strategy program called the Tolvaptan for ADPKD Shared System REMS</strong></li></ul></div><p class="subtitle"><strong>CONTRAINDICATIONS:</strong></p><ul><li>History, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease</li><li>Taking strong CYP3A inhibitors</li><li>With uncorrected abnormal blood sodium concentrations</li><li>Unable to sense or respond to thirst</li><li>Hypovolemia</li><li>Hypersensitivity (e.g., anaphylaxis, rash) to JYNARQUE or any component of the product</li><li>Uncorrected urinary outflow obstruction</li><li>Anuria</li></ul><p><strong>Serious Liver Injury:</strong> JYNARQUE can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported in the post-marketing ADPKD&nbsp;experience. Discontinuation in response to laboratory abnormalities or signs or symptoms of liver injury (such as fatigue, anorexia, nausea, right upper abdominal discomfort, vomiting, fever, rash, pruritus, icterus, dark urine or jaundice) can reduce the risk of severe hepatotoxicity. To reduce the risk of significant or irreversible liver injury, assess ALT, AST and bilirubin prior to initiating JYNARQUE, at 2 weeks and 4 weeks after initiation, then monthly for 18 months and every 3 months thereafter.</p><p><strong>Hypernatremia, Dehydration and Hypovolemia:</strong> JYNARQUE therapy increases free water clearance which can lead to dehydration, hypovolemia and hypernatremia. Instruct patients to drink water when thirsty, and throughout the day and night if awake. Monitor for weight loss, tachycardia and hypotension because they may signal dehydration. Ensure abnormalities in sodium concentrations are corrected before initiating therapy. If serum sodium increases above normal or the patient becomes hypovolemic or dehydrated and fluid intake cannot be increased, suspend JYNARQUE until serum sodium, hydration status and volume status parameters are within the normal range.</p><p><strong>Inhibitors of CYP3A:</strong> Concomitant use of JYNARQUE with drugs that are moderate or strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, lopinavir/ritonavir, indinavir/ritonavir, ritonavir, and conivaptan) increases tolvaptan exposure. Use with strong CYP3A inhibitors is contraindicated; dose reduction of JYNARQUE is recommended for patients taking moderate CYP3A inhibitors. Patients should avoid grapefruit juice beverages while taking JYNARQUE.</p><p><strong>Adverse Reactions:</strong> Most common observed adverse reactions with JYNARQUE (incidence &gt;10% and at least twice that for placebo) were thirst, polyuria, nocturia, pollakiuria and polydipsia.</p><p><strong>Other Drug Interactions:</strong></p><ul><li><strong>Strong CYP3A Inducers:</strong> Co-administration with strong CYP3A inducers reduces exposure to JYNARQUE. Avoid concomitant use of JYNARQUE with strong CYP3A inducers</li><li><strong>V<sub>2</sub>-Receptor Agonist:</strong> Tolvaptan interferes with the&nbsp;V<sub>2</sub>-agonist activity of desmopressin (dDAVP). Avoid concomitant use of JYNARQUE with a&nbsp;V<sub>2</sub>-agonist</li></ul><p><strong>Pregnancy and Lactation:</strong> Based on animal data, JYNARQUE may cause fetal harm. In general, JYNARQUE should be discontinued during pregnancy. Advise women not to breastfeed during treatment with JYNARQUE.</p><p class="reporting">To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at <span class="nobr">1-800-438-9927</span> or FDA at <span class="nobr">1-800-FDA-1088</span> (<a class="cyan ext-link" href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program" data-analytics-name="www.fda.gov/medwatch">www.fda.gov/medwatch</a>).</p><p>Please see <a class="cyan external-link-popup-disabled" href="https://www.otsuka-us.com/media/static/JYNARQUE-PI.pdf" target="_blank" data-analytics-name="FULL PRESCRIBING INFORMATION">FULL PRESCRIBING INFORMATION</a>, including <strong>BOXED WARNING</strong>.</p>

    </div>
	</div>

	<!--</div>--><!--/#isi-drawer-wrapper-->

</section>
<style>
	
	.isi-tray {
		left: 0%;
		width: 100%;
	}
	.isi-drawer-expanded {
		height: 220px;
	}
	.isi-drawer-collapsed {
		height: 200px;
	}

    .isi-tray.isi-drawer-expanded .isi-content-wrap,
    .isi-tray.isi-drawer-expanded .isi-content-wrap>div {
        height: calc(50vh - 380px);
    }
    @media all and (min-width: 768px) {
        .isi-tray.isi-drawer-expanded .isi-content-wrap,
        .isi-tray.isi-drawer-expanded .isi-content-wrap>div {
            height: calc(50vh - 220px);
        }
    }
}

</style>


    
    
<footer>
    <div class="footer-container">

                <div class="footer-row">
            <div class="footer-nav">
                  <div class="region region-footer-nav">
    <nav role="navigation" aria-labelledby="block-jynarque-hcp-footer-menu" id="block-jynarque-hcp-footer" class="custom-block--jynarque-hcp-footer" data-test='privacy-menu'>
            
  <div class="visually-hidden" id="block-jynarque-hcp-footer-menu">Footer menu</div>
  

        
              <ul block="block-jynarque-hcp-footer" region="footer_nav" data-test="footer-menu">
              <li>

                <a href="https://www.otsuka-us.com/privacy-policy" target="_blank" class="ext-link">Privacy Policy</a>
              </li>
          <li>

                <a href="https://www.otsuka-us.com/terms-and-conditions" target="_blank" class="ext-link">Terms of Use</a>
              </li>
        </ul>
  


  </nav>

  </div>

            </div>
        </div>
        
        <div id="mobile-tablet-branding" class="footer-row">
            <div class="footer-otsuka">
                  <div class="region region-footer-branding-otsuka">
    <div id="block-otsukabrandingfooter" class="custom-block--otsukabrandingfooter block-content-otsuka-branding-footer block-content-basic-block">
  
    
      


                    <div class="body "><p><a class="ext-link" href="https://www.otsuka-us.com/" data-analytics-name="Otsuka America Pharmaceutical, Inc., Logo" target="_blank" aria-label=" (opens in a new window)"><img src="sites/g/files/qhldwo11641/files/inline-images/otsuka_logo2.png" data-entity-uuid="c466d6d1-5a41-4fbc-b91a-a1c601e50800" data-entity-type="file" alt="Otsuka America Pharmaceutical, Inc., Logo" width="492" height="98" loading="lazy"></a></p></div>
            
  </div>

  </div>

            </div>
        </div>

        <div id="desktop-bottom-footer-row">
            <div class="desktop-credits-wrapper">
                <div class="footer-row">
                        <div class="footer-otsuka desktop" data-test='navbar-branding'>
                              <div class="region region-footer-branding-otsuka">
    <div id="block-otsukabrandingfooter" class="custom-block--otsukabrandingfooter block-content-otsuka-branding-footer block-content-basic-block">
  
    
      


                    <div class="body "><p><a class="ext-link" href="https://www.otsuka-us.com/" data-analytics-name="Otsuka America Pharmaceutical, Inc., Logo" target="_blank" aria-label=" (opens in a new window)"><img src="sites/g/files/qhldwo11641/files/inline-images/otsuka_logo2.png" data-entity-uuid="c466d6d1-5a41-4fbc-b91a-a1c601e50800" data-entity-type="file" alt="Otsuka America Pharmaceutical, Inc., Logo" width="492" height="98" loading="lazy"></a></p></div>
            
  </div>

  </div>

                        </div>
                        <div class="footer-credits">
                            
                        </div>
                </div>

                <div class="footer-row">
                    <div class="footer-mobile-left">
                        <div class="footer-copyright" data-test='copyright'>
                              <div class="region region-footer-copyright">
    <div id="block-otsukacopyright" class="custom-block--otsukacopyright">
  
    
      ©2025 Otsuka America Pharmaceutical, Inc.
  </div>
<div id="block-sitecopyright" class="custom-block--sitecopyright block-content-site-copyright block-content-basic-block">
  
    
      


                    <div class="body "><p>All rights reserved.</p></div>
            
  </div>

  </div>

                        </div>
                        <div class="footer-review-date">
                              <div class="region region-footer-review-date">
    <div id="block-prcdate" class="custom-block--prcdate">
  
    
      <span class="prc-info-date" data-test='prc-date'>April 2025</span>
  </div>


  </div>

                        </div>
                        <div class="footer-prc-code">
                              <div class="region region-footer-prc-code">
    <div id="block-prccode" class="custom-block--prccode">
  
    
      <span class="prc-info-code" data-test='prc-code'>10US25EBP0100</span>
  </div>


  </div>

                        </div>
                    </div>
                </div>
            </div>
            
        </div>    
    </div>
</footer>    <script src="sites/g/files/qhldwo11641/files/js/optimized/js_tEHmcBxEtX6BgWeJu5ZD5tm1Q1doD0-qkAYcr82kD4k.ynaH4lVgxzvT_2P4No6c_p66xrTgrBFkNVbFFBpCUA4795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_zlo20VYOOfYZofFek2aZfqeW7-4I4EnKhy1r0DXNaj8.7IfozJnZAs3R904IPk7xrwdaj2Mk4mNuyTLjYiVgwSE795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_FUSBloir72XJaumADc1kuF-akuqxPIm_1cauBoAUxbU.EPBu7ULaYMDqpSfEXZ3tMfGqx0T05UwLQ5yXSv8tZOY795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_6hVk6czRLgyFjweT4xpjMUA9hhm2jkXyB_GcKxzYZ4U.cOy7LcP7GODWln2-XoTmf41wfyP6LFg-ffmSFy1o58I795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_kGL06WXHJXOdBVjSdXjbeeqdQbRzRTBJYfnI2vp2XKU.FAssV4Yu2ZZuldnqwxwtMa_1UbYOTEhp8VAUCU8bT1c795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_0zNYOOwPYTOS540Y_9OtAEyUMkXTl7VfjTsi0W8OZ8w.iPD_LtdmQKwvg-ezDUsfh1_2J-3IJUU76tfhyb0s7aY795c.js?v=1.13.2"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_5lyEgtuYzFbknt789sXbvgY6WOEBhn68zCRaGR5wIJc.pydd31qeaVwnZ7zmVFZER7RdslYTSa4L05Z96Bj0rpAfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_G8podNJjOsxKvo_RVe4-f79_ME43boCp5OhhwF87kOc.CmHewv09bU-2iMTQUA9fYmgUfGdx8v6eCV0c0HTKVv0fe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_RpLV1j1SEgkAOBNxIxvzKXRlefOlhPa03lpGt46bJEg.ipSHo_VRPfgKJstENA8BEd0ZaAk6UUuLrs-5LtKGyFwfe04.js?v=10.5.0"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_mFzUkjUxStqgHC8aG7xRbdL6fE1PCi6EiNgqsEIWhqc.akPIL5F6ygowEntokyWY4_Tg4pNQtEi97UIJcojA29M1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_e0nUrwBznnMVmKyRC1nKSrKyAbNpXG9b7kq062lD5Po.7IsIMR5pUjQ40qsxW43segoWUiTLhBs0bg6XNhx77Do1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/dist/js/02-molecules/accordion/accordion1cee.js?t5xpr9" defer></script>
<script src="https://cdn.jsdelivr.net/npm/react-player/dist/ReactPlayer.standalone.js"></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/dist/js/03-organisms/video/videoReact/videoReact1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/themes/site/themes/custom/jynarque_hcp/legacy/assets/build/js/components/paragraph/wrapper-tabbed1cee.js?t5xpr9" defer></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_vJSVBi47jJeNV6Li9watXOS2ATz59rVDv4gpdmt8XF0.YPmGs1GFTh-5SRVLtW4tSrVpZz12_Zvr_toLDL8gBfc1cee.js?t5xpr9"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_rpx3pOPcK6hnLQR-Fef4P6UMSJh-ihuV9hqkMm_cMdk.vTghGNUkYqEi22uPg-gGp3H22SpaHZoLjn_xZk1ITwka0fc.js?v=1.x"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_8rI11XUPmo8bNSGc51T6ByOCso4FQ5AktRkneJJL7Nc.AyNUrL50y9uFK4-l6wxy1y5SzvrnEuWYvX8Ai1_oSMca0fc.js?v=1.x"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_aGpgzbkylt8snB-EXgmHtxvxOZAT-qDmrVPgkGVG71I.ojHXLPZwCg6JiUQKM9w4QZF_TUslDSaGc0h3XjA--Zwa0fc.js?v=1.x"></script>
<script src="sites/g/files/qhldwo11641/files/js/optimized/js_t6WcaYLAw6hjWSihMsQXThEsPYFBj0NBE18VKsjijws.EX9XtAmarEWHxG8VqWLQlmsKC8tS6zrY_UhL31ekHLca0fc.js?v=1.x"></script>

    </div>
  </body>


</html>
